Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
Antiviral Research|November 18, 2005
Hepatitis B virus-neutralizing anti-pre-S1 human antibody fragments from large naïve antibody phage librarySae-Gwang Park, Yong-Joo Jeong, Yong-Yi Lee, et al.International Journal of Molecular Medicine|May 9, 2015
3,3'-Diindolylmethane inhibits VEGF expression through the HIF-1α and NF-κB pathways in human retinal pigment epithelial cells under chemical hypoxic conditionsHongzoo Park, Dae-Sung Lee, Mi-Jin Yim, et al.International Journal of Molecular Medicine|December 17, 2013
The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cellsWon-Kyo Jung, Chang-Min Lee, Dae-Sung Lee, et al.European Journal of Pharmacology|June 24, 2017
Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivoSun Young Ma, Won Sun Park, Dae-Sung Lee, et al.International Journal of Oncology|December 7, 2016
NecroX-5 prevents breast cancer metastasis by AKT inhibition via reducing intracellular calcium levelsJin-Hee Park, Hyoung Kyu Kim, Hana Jung, et al.Journal of Biosciences|November 26, 2011
Polyopes affinis alleviates airway inflammation in a murine model of allergic asthmaDae-Sung Lee, Won Sun Park, Soo-Jin Heo, et al.Cancer Letters|January 22, 2009
Tetra-arsenic oxide (Tetras) enhances radiation sensitivity of solid tumors by anti-vascular effectSae-Gwang Park, Jeong-Joo Jung, Hae Jeong Won, et al.Pharmaceutical Biology|June 13, 2014
Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cellsMi Suk Cho, Won Sun Park, Won-Kyo Jung, et al.Viral Immunology|March 24, 2006
Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 V(H) mutant librarySae-Gwang Park, Young-Joo Jung, Young-Yi Lee, et al.Oncoimmunology|May 4, 2018
A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in miceJae-Hyeog Choi, Ki Hyang Kim, Kug-Hwan Roh, et al.Pageof 13